HIV Patients Cohort (OVIHD)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02203006|
Recruitment Status : Recruiting
First Posted : July 29, 2014
Last Update Posted : March 25, 2019
|Condition or disease||Intervention/treatment||Phase|
|Patients Affected by the HIV||Biological: OVIHD||Not Applicable|
Since the arrival of highly active tritherapies, HIV infection became mainly an ambulatory chronic pathology centred on a long term care taking into account the complication of long-term treatment as well as the arisen of new problem bound to a prolonged survival and ageing. So the care is more and more in a prevention and screening approach with in particular the care of metabolic and cardiovascular complication due to antiretroviral treatment.
As a reorganization of the coverage of the HIV infected people take place on the Hotel Dieu Hospital it thus seems important to double this care optimization with a clinical research side. This will be done in constituting an HIV patient cohort including a blood sample collection to contribute to the vigilance of the complication to due the infection.
Our ultimate objective is to optimize the selection of the treatment. It is important to do it to be able to have, on many years duration, precise clinical information and biological sample allowing to realize later some assay and analyse the influence of some genetic markers.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||1296 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Constitution of an Open Monocentric Cohort of HIV Infected Patients|
|Actual Study Start Date :||October 19, 2011|
|Estimated Primary Completion Date :||October 2030|
|Estimated Study Completion Date :||April 2031|
Cohort and a blood sample collection will be done with data and blood of HIV infected patients
7 ml of blood will be taken during a follow-up consultation and kept in a biological collection. Clinical data will be collected in a database.
Other Name: Blood sample
- HIV infection [ Time Frame: 10 years ]The HIV cohort will be constituted in collecting cardiovascular, neurological clinical data and medical past history (in case of women patient)
- Comorbidity and complication in HIV infected patients [ Time Frame: 10 years ]The HIV cohort will be constituted in collecting cardiovascular, neurological clinical data and medical past history (in case of women patient)
- efficiency of the current antiretroviral therapeutic diets [ Time Frame: 10 years ]The HIV cohort will be constituted in collecting cardiovascular, neurological clinical data and medical past history (in case of women patient)
- Blood sample collection [ Time Frame: 10 years ]To put in relation the clinical-biological relevant biological or genetic data of the follow-up a blood sample will be constituted. 7 ml will be taken to each patient and kept in a collection
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02203006
|Contact: Jean Paul Viard, MD||+331 42 34 88 41 / firstname.lastname@example.org|
|Contact: Sandra COLAS||00 33 1 71 19 64 email@example.com|
|Study Director:||Jean Marc Tréluyer, MD, PhD||Assistance Publique - Hôpitaux de Paris|